ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

Science Policy: NCAB Opposes Law Making Data Available Under FOIA; Individuals Encouraged To Send comments To OMB

March 19, 1999

Emory Executive Objects to Report On Merit review

July 22, 1977

Henschke Responds To Questions from The New York Times

April 29, 2011

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007

In Brief: NCAB Dec. Meeting Includes Biologics Symposium; Epidemiology Center Grant Program Disapproved

November 29, 1985

NCI Breast Cancer Overview Report Competed

August 5, 1988